Application of high‐Z gold nanoparticles in targeted cancer radiotherapy—pharmacokinetic modeling, Monte Carlo simulation and radiobiological effect modeling.
High‐Z gold nanoparticles (AuNPs) conjugated to a targeting antibody can help to improve tumor control in radiotherapy while simultaneously minimizing radiotoxicity to adjacent healthy tissue. This paper summarizes the main findings of a joint research program which applied AuNP‐conjugates in preclinical modeling of radiotherapy at the Klinikum rechts der Isar, Technical University of Munich and Helmholtz Zentrum München. A pharmacokinetic model of superparamagnetic iron oxide nanoparticles was developed in preparation for a model simulating.
FörderungenTUM Graduate School Internationalization Grant Technische Universitat Munchen (TUM) within the DFG funding Ministry of Science and Higher Education of The Russian Federation National Institutes of Health (NIH)/National Cancer Institute (NCI) FAPESP foundation in Brazil CNPq DFG